0000899243-22-017084.txt : 20220506
0000899243-22-017084.hdr.sgml : 20220506
20220506160542
ACCESSION NUMBER: 0000899243-22-017084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220505
FILED AS OF DATE: 20220506
DATE AS OF CHANGE: 20220506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klee Justin B.
CENTRAL INDEX KEY: 0001898314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41199
FILM NUMBER: 22901021
MAIL ADDRESS:
STREET 1: C/O AMYLYX PHARMACEUTICALS, INC.
STREET 2: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658551
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464600503
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-683-0917
MAIL ADDRESS:
STREET 1: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-05
0
0001658551
Amylyx Pharmaceuticals, Inc.
AMLX
0001898314
Klee Justin B.
C/O AMYLYX PHARMACEUTICALS, INC.
43 THORNDIKE STREET
CAMBRIDGE
MA
02141
1
1
0
0
Co-Chief Executive Officer
Common Stock
2022-05-05
4
M
0
334520
0.37
A
2898585
D
Stock Option (right to buy)
0.37
2022-05-05
4
M
0
334520
0.00
D
2023-02-16
Common Stock
334520
0
D
This option is fully vested and exercisable.
/s/ Justin B. Klee
2022-05-06